Ashton Thomas Private Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Ashton Thomas Private Wealth, LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $20.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$20.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 59,585 | $8.3M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 70,117 | $3.9M |
| INCYIncyte Corp. | 33,597 | $3.2M |
| SNYSanofi | 61,316 | $3.0M |
| EXELEXELIXIS, INC. | 26,638 | $1.1M |
| LGNDLigand Pharmaceuticals Incorporated | 2,194 | $438K |
| ANIPANI PHARMACEUTICALS INC | 3,972 | $305K |
| ARGXARGENX SE | 284 | $207K |
| SCLXSCILEX HOLDING CO | 17,989 | $120K |
| PBYIPUMA BIOTECHNOLOGY, INC. | 13,500 | $86K |
| MRKRMarker Therapeutics, Inc. | 16,400 | $21K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.